The predictive utility of placental growth factor testing between 26 and 28 weeks in screening for preterm delivery due to placenta-mediated complications: A prospective cohort study in 5,000 apparently low-risk pregnancies
The predictive utility of placental growth factor testing between 26 and 28 weeks in screening for preterm delivery due to placenta-mediated complications: A prospective cohort study in 5,000 apparently low-risk pregnancies
批准号:
486451
负责人:
Gladstone Rachel A
金额:
$1.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-12-01 至 2023-12-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pre-eclampsia is a potentially life-threatening pregnancy complication, causing elevated blood pressure with injury to important organs. It is strongly associated with abnormal development of and progressive damage to the placenta. There is no cure for th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金